|
|
| 產(chǎn)品基本信息 |
|
| 產(chǎn)品編號：C781351 |
| 產(chǎn)品名稱：CP-690550 Citrate (Tofacitinib Citrate) |
| 產(chǎn)品CAS：540737-29-9 |
| 規(guī)格含量：10mg |
| 產(chǎn)品價(jià)格：面議 |
| 聯(lián)系我們: |
 |
|
 |
|
|
| 產(chǎn)品詳細(xì)介紹 |
| 標(biāo)準(zhǔn)品編號: |
C781351 |
| 名稱: |
CP-690550 Citrate (Tofacitinib Citrate) |
| 別名: |
(3R,4R)-4-Methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-1-piperidinepropanenitrile; 2-Hydroxy-1,2,3-propanetricarboxylate; (3R,4R)-1-(Cyanoacetyl)-4- methyl-N-methyl-N-1H-pyrrolo[2,3-d]pyrimidin-4-yl-3-piperidinamine 2-Hydroxy-1,2,3-propanetricarboxylate; CP 690500-10; CP 690550-10; Tofacitinib Citrate; |
| CAS號: |
540737-29-9 |
| 參考CAS: |
477600-75-2-free base |
| 分子式: |
C??H??N?O? |
| 外觀: |
白色至Pale Pink Solid |
| 熔點(diǎn): |
>195°C (dec.) |
| 分子量: |
504.49 |
| 儲存: |
冰箱保存 |
| 溶解度: |
DMSO, Methanol (Slightly, Heated), Water (Slightly, Heated) |
| 類別: |
Standards; Enzyme Activators and Inhibitors; Pharmaceutical/API Drug Impurities/Metabolites; |
| 應(yīng)用: |
CP-690550 is a pyrrolo[2,3-d]pyrimidine derivative, as Janus kinase inhibitor for treatment of rheumatoid arthritis. |
| 參考文獻(xiàn) |
|
|
|
|
|
|
?您的位置：
